Sinovac Biotech Ltd.
NASDAQ: SVA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Wei Dong Yin
- Employees
- 1,959
- Headquarters
- Beijing, China
- IPO year
- 2003
- Market cap
- $464.9M
- Website
- http://www.sinovacbio.com
Loading SVA…
Loading profile data…Frequently asked questions about SVA
What does Sinovac Biotech Ltd. (SVA) do?
Sinovac Biotech Ltd. is a biopharmaceutical firm primarily dedicated to the discovery, research, manufacturing, and sales of vaccines aimed at combating infectious human diseases across the People's Republic of China. Its extensive product range encompasses immunizations against Hepatitis A and B; hand, foot, and mouth disease caused by Enterovi...
Where does SVA trade?
Sinovac Biotech Ltd. (SVA) trades on the NASDAQ Global Select.
What sector is SVA in?
Sinovac Biotech Ltd. (SVA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Sinovac Biotech Ltd.?
Wei Dong Yin is the chief executive officer of Sinovac Biotech Ltd. (SVA).
Where is Sinovac Biotech Ltd. headquartered?
Sinovac Biotech Ltd. is headquartered in China.
Does SVA pay a dividend?
Yes — Sinovac Biotech Ltd. (SVA) paid a trailing twelve-month dividend of USD 55.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SVA go public?
Sinovac Biotech Ltd. (SVA) completed its initial public offering in 2003.